Brief: Arch Biopartners Inc Says Veterans Affairs San Diego Healthcare System Has Started Recruiting Patients For Phase II Trial Of Its Lead Drug LSALT Peptide
10/12/2020 12:34
Dec 10 (Reuters) - Arch Biopartners Inc ARCH.V :
* ARCH BIOPARTNERS INC - VETERANS AFFAIRS SAN DIEGO
HEALTHCARE
SYSTEM HAS STARTED RECRUITING PATIENTS FOR PHASE II TRIAL OF ITS
LEAD DRUG LSALT PEPTIDE
Source text for Eikon: ID:nGNX9gtrT2
Further company coverage: ARCH.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arch Biopartners
See all newsBrief: Arch Biopartners To Expand Phase Ii Cardiac Surgery-Associated Acute Kidney Injury Trial To The US
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Strengthens Its Position As A Leading Kidney Therapeutics Company With The Acquisition Of A Breakthrough Platform To Develop New Drugs Targeting Chronic Kidney Disease (Ckd)
Brief: Arch Biopartners Closes Non-Brokered Private Placement
Brief: Arch Biopartners Announces Ontario Research Ethics Board Approval To Start Phase II Trial For LSALT Peptide